scispace - formally typeset
J

Joseph A. Sivak

Researcher at Duke University

Publications -  19
Citations -  209

Joseph A. Sivak is an academic researcher from Duke University. The author has contributed to research in topics: Aortic valve & Aortic valve stenosis. The author has an hindex of 7, co-authored 18 publications receiving 141 citations. Previous affiliations of Joseph A. Sivak include University of North Carolina at Chapel Hill.

Papers
More filters
Journal ArticleDOI

Prevalence and Outcomes of Left-Sided Valvular Heart Disease Associated With Chronic Kidney Disease.

TL;DR: Prevalence of at least mild AS and MR is substantially higher and is associated with significantly lower survival among patients with versus without CKD, with increasingly worse outcomes for CKD patients with increasing AS/MR severity.
Journal ArticleDOI

Assessment of the physiologic contribution of right atrial function to total right heart function in patients with and without pulmonary arterial hypertension.

TL;DR: RA function accounts for a significantly greater proportion of total right heart function in patients with PAH than in normal subjects.
Journal ArticleDOI

An Approach to Improve the Negative Predictive Value and Clinical Utility of Transthoracic Echocardiography in Suspected Native Valve Infective Endocarditis.

TL;DR: The ability of TTE to exclude vegetation in patients is excellent when strict criteria for negative results are applied, and in patients at low to intermediate risk with strict negative results on TTE, follow-up TEE may be unnecessary.
Journal ArticleDOI

Grading Aortic Stenosis With Mean Gradient and Aortic Valve Area: A Comparison Between Preoperative Transthoracic and Precardiopulmonary Bypass Transesophageal Echocardiography

TL;DR: The hypothesis that pre-CPB TEE generates different PGm and AVA values compared with preoperative transthoracic values in the same patients was confirmed and these differences often underestimate AS severity.
Journal ArticleDOI

Use of outcome measures in pulmonary hypertension clinical trials.

TL;DR: The use of these surrogate measures has evolved significantly over time with increasing use of patient-centered endpoints and decreasing or stable use of imaging and invasive measures in contemporary clinical practice as mentioned in this paper.